|
2025
|
Invention
|
Hyaluronidase enzyme formulations for high volume administration.
In one aspect, the present dis... |
|
|
Invention
|
Combination administration of gamma globulin and hyaluronidases to determine injection times. The... |
|
|
Invention
|
Autoinjector. An injector includes a housing, a medicament container disposed within the housing,... |
|
|
Invention
|
Combination therapy with antibody-drug conjugates and hyaluronidases. Provided are combination do... |
|
|
Invention
|
Ph20 polypeptide variants, formulations and uses thereof.
Modified PH20 hyaluronidase polypeptid... |
|
|
P/S
|
Drug delivery agents in the form of liquid for subcutaneous delivery that facilitate the delivery... |
|
|
P/S
|
Drug delivery agents in the form of subcutaneous delivery
that facilitate the delivery of pharma... |
|
|
Invention
|
Injector. An injector includes a housing extending along a longitudinal axis, the housing having ... |
|
2024
|
Invention
|
Injector.
An injector includes a housing extending along a longitudinal axis, the housing has a ... |
|
|
Invention
|
Platform attachment for angled subcutaneous injection and methods of use thereof. In one aspect, ... |
|
|
Invention
|
Autoinjector with three-position needle guard. An injector includes a housing having a proximal e... |
|
|
P/S
|
Drug delivery agents in the form of liquid for subcutaneous
delivery that facilitate the deliver... |
|
|
Invention
|
Prefilled syringe injector.
A jet injector that includes a prefilled syringe. The syringe includ... |
|
|
P/S
|
Drug delivery agents in the form of subcutaneous delivery that facilitate the delivery of pharmac... |
|
|
Invention
|
Prefilled autoinfusion device. In one aspect, the present disclosure provides a prefilled autoinf... |
|
|
Invention
|
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions.
Prov... |
|
|
Invention
|
Antibody compositions and methods of use thereof.
The disclosure provides pharmaceutical composi... |
|
|
Invention
|
Ph20 polypeptide variants, formulations and uses thereof. Modified PH20 hyaluronidase polypeptide... |
|
|
P/S
|
Drug delivery agents in the form of liquid for subcutaneous delivery that facilitate the deliver... |
|
|
Invention
|
Methods of treating tumors.
The disclosure provides pharmaceutical compositions comprising an an... |
|
|
P/S
|
administration of a discount program enabling patients to obtain discounts on prescription drugs ... |
|
|
P/S
|
insurance benefits verification and prior authorization assistance; copay assistance programs, na... |
|
2023
|
Invention
|
Hyaluronidase enzyme formulations for high volume administration. In one aspect, the present disc... |
|
|
Invention
|
Button actuated autoinjector. An injector includes a housing that has a proximal end and a distal... |
|
|
Invention
|
Injection device |
|
|
Invention
|
Ph20 polypeptide variants with a modification at position 324 of the ph20 polypeptide and a metho... |
|
|
Invention
|
Ph20 polypeptide variants with a modification at position 309 of the ph20 polypeptide and a metho... |
|
|
Invention
|
Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceut... |
|
|
Invention
|
Dosing regimen.
Provided are combination dosing regimens comprising administering cabotegravir a... |
|
2022
|
Invention
|
Combination therapy with a hyaluronan-degrading enzyme and an immune checkpoint inhibitor.
Provi... |
|
2016
|
P/S
|
Patient recruitment services, namely, recruiting patients for participation in clinical trials; p... |
|
2015
|
P/S
|
Scientific research and development services in the field of pharmaceuticals and drug delivery de... |
|
|
P/S
|
Scientific research, development and integration services
for pharmaceuticals and drug delivery ... |
|
|
P/S
|
scientific research and development services for the integration of technologies, therapies, and ... |
|
2012
|
P/S
|
Enzymes for medical purposes, namely, facilitating delivery
of fluids or pharmaceuticals, and ph... |
|
2011
|
P/S
|
Enzymes for medical purposes, namely, facilitating delivery of fluids or pharmaceuticals, and pha... |
|
2010
|
P/S
|
Enzymes for medical purposes, namely, facilitating delivery of pharmaceuticals, and pharmaceutica... |
|
|
P/S
|
Enzymes for medical purposes, namely, facilitating delivery
of pharmaceuticals, and pharmaceutic... |
|
2009
|
P/S
|
Hyaluronidase in injectable form. |
|
2006
|
P/S
|
Hyaluronidase in injectable form. |
|
2004
|
P/S
|
recombinant human hyaluronidase formulation for use in in-vitro fertilization procedures |
|
2003
|
P/S
|
HYALURONIDASE IN INJECTABLE FORM |
